TRANSFOTEC
ActiveSummary
TRANSFOTEC has been active since 1991 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €463,442 and a net result of €24,905. Equity is growing by about 9.6% per year across the filed financial years. The computed 12-month bankruptcy probability is 0.1% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
27-02
NBB filing
Annual accounts filed
financial year 2025 · abbreviated format · 27 days late
2025
27-01
NBB filing
Annual accounts filed
financial year 2024 · abbreviated format
2024
30-06
Financial
Liquidity more than 46 timescurrent ratio 1.08
Current ratio from 0.02 to 1.08; short-term debt falls from €53,238 to €33,602.
18-01
NBB filing
Annual accounts filed
financial year 2023 · abbreviated format
2023
30-06
Financial
Highest result from 2019 to 2025net €42,938 ▲18.8%
Operating result €64,077, net result €42,938, both a record.
07-02
NBB filing
Annual accounts filed
financial year 2022 · abbreviated format · 7 days late
2022
27-01
NBB filing
Annual accounts filed
financial year 2021 · abbreviated format
2021
28-01
NBB filing
Annual accounts filed
financial year 2020 · abbreviated format
2020
30-06
Financial
Weakest financial yearnet €20,640 ▼39%
Net result drops to €20,640, the lowest in the series; recovery starts the following year.
2019
18-12
NBB filing
Annual accounts filed
financial year 2019 · abbreviated format
2018
19-12
NBB filing
Annual accounts filed
financial year 2018 · abbreviated format
31-01
NBB filing
Annual accounts filed
financial year 2017 · abbreviated format
2016
14-12
NBB filing
Annual accounts filed
financial year 2016 · abbreviated format
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 33 annual accounts filed, the latest 10 are here; all 33 are under Financials.
0 of 5 deeds read
About the unread acts
We know of 5 Belgian Official Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.